BioCentury | Jul 3, 2020
Finance

On heels of $100M raise, Annexon joins burgeoning IPO queue

...Redmile Group, Federated Hermes Kaufmann Funds, RTW Investments and Sphera Funds, plus existing Immatics investors dievini Hopp BioTech...
BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...ministry document. On Monday, Germany’s Federal Ministry of Economics and Energy and CureVac majority shareholder dievini Hopp Biotech...
BioCentury | Jun 18, 2020
Product Development

Vaccines from CureVac, Imperial enter the clinic as PDS finds a partner for its product

...Christof Hettich told BioCentury. He is a co-founder and managing director of CureVac’s majority shareholder dievini Hopp BioTech...
BioCentury | Jun 15, 2020
Finance

Amid concerns of COVID-19 vaccine nationalism, Germany takes €300M stake in CureVac

...COVID-19 Vaccine Nationalism” ). Christof Hettich, co-founder and managing director of the company’s majority shareholder dievini Hopp BioTech...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...Federated Hermes Kaufmann Funds, RTW Investments, Sphera Funds, an additional undisclosed investor and existing shareholders dievini Hopp BioTech...
BioCentury | Mar 16, 2020
Management Tracks

CureVac CEO Hoerr takes leave of absence; German biotech rejects reports of U.S. approach for COVID-19 vaccine

...“COVID-19: A Growing List of New Vaccines and Therapies in Development” ). CureVac’s largest shareholder, dievini Hopp BioTech...
BioCentury | Oct 11, 2018
Financial News

Ophthalmology company Novaliq raises $53M

...Ophthalmology company Novaliq GmbH (Heidelberg, Germany) raised $53 million on Oct. 11 from existing investor dievini Hopp BioTech...
...Ophthalmology Innovation Summit in Chicago on Oct. 25. Novaliq GmbH, Heidelberg, Germany Jaime De Leon CyclASol Mysol, perfluorohexyloctane (NOV03) dievini Hopp BioTech...
BioCentury | May 18, 2018
Finance

China comes to Europe

...Therapeutic vaccines Cancer and infectious diseases Immatics Biotechnologies GmbH (Germany) $58.0 Series E Wellington Partners, dievini Hopp BioTech...
BioCentury | Oct 6, 2017
Financial News

Immatics raises $58M in series E

...Immatics Biotechnologies GmbH (Tuebingen, Germany) raised $58 million in a series E round. Existing investors dievini Hopp BioTech...
BioCentury | Oct 4, 2017
Financial News

Immatics raises $58M in series E

...Immatics Biotechnologies GmbH (Tuebingen, Germany) raised $58 million in a series E round. Existing investors dievini Hopp BioTech...
Items per page:
1 - 10 of 76
BioCentury | Jul 3, 2020
Finance

On heels of $100M raise, Annexon joins burgeoning IPO queue

...Redmile Group, Federated Hermes Kaufmann Funds, RTW Investments and Sphera Funds, plus existing Immatics investors dievini Hopp BioTech...
BioCentury | Jun 18, 2020
Finance

June 17 Quick Takes: Constellation, Celldex raise follow-ons; plus CureVac quiet on IPO chatter and venture cash for GreenLight, TILT, DiogenX

...ministry document. On Monday, Germany’s Federal Ministry of Economics and Energy and CureVac majority shareholder dievini Hopp Biotech...
BioCentury | Jun 18, 2020
Product Development

Vaccines from CureVac, Imperial enter the clinic as PDS finds a partner for its product

...Christof Hettich told BioCentury. He is a co-founder and managing director of CureVac’s majority shareholder dievini Hopp BioTech...
BioCentury | Jun 15, 2020
Finance

Amid concerns of COVID-19 vaccine nationalism, Germany takes €300M stake in CureVac

...COVID-19 Vaccine Nationalism” ). Christof Hettich, co-founder and managing director of the company’s majority shareholder dievini Hopp BioTech...
BioCentury | Mar 18, 2020
Finance

March 17 Quick Takes: Tempus, Circle, Immatics, Exuma, CFIUS

...Federated Hermes Kaufmann Funds, RTW Investments, Sphera Funds, an additional undisclosed investor and existing shareholders dievini Hopp BioTech...
BioCentury | Mar 16, 2020
Management Tracks

CureVac CEO Hoerr takes leave of absence; German biotech rejects reports of U.S. approach for COVID-19 vaccine

...“COVID-19: A Growing List of New Vaccines and Therapies in Development” ). CureVac’s largest shareholder, dievini Hopp BioTech...
BioCentury | Oct 11, 2018
Financial News

Ophthalmology company Novaliq raises $53M

...Ophthalmology company Novaliq GmbH (Heidelberg, Germany) raised $53 million on Oct. 11 from existing investor dievini Hopp BioTech...
...Ophthalmology Innovation Summit in Chicago on Oct. 25. Novaliq GmbH, Heidelberg, Germany Jaime De Leon CyclASol Mysol, perfluorohexyloctane (NOV03) dievini Hopp BioTech...
BioCentury | May 18, 2018
Finance

China comes to Europe

...Therapeutic vaccines Cancer and infectious diseases Immatics Biotechnologies GmbH (Germany) $58.0 Series E Wellington Partners, dievini Hopp BioTech...
BioCentury | Oct 6, 2017
Financial News

Immatics raises $58M in series E

...Immatics Biotechnologies GmbH (Tuebingen, Germany) raised $58 million in a series E round. Existing investors dievini Hopp BioTech...
BioCentury | Oct 4, 2017
Financial News

Immatics raises $58M in series E

...Immatics Biotechnologies GmbH (Tuebingen, Germany) raised $58 million in a series E round. Existing investors dievini Hopp BioTech...
Items per page:
1 - 10 of 76